Neurogastrx
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $105M
Investors
- 7
About Neurogastrx
Neurogastrx, Inc.Founded in 2012 and headquartered in Woburn, US, Neurogastrx, Inc. specializes in developing innovative solutions for gastrointestinal conditions. Founders Cyril De Colle, Daniel Amoako, and Pankaj Pasricha have experience in the biopharmaceutical field, contributing to the company’s strategic direction.Neurogastrx, Inc. specializes in the discovery and development of innovative biopharmaceutical therapies aimed at addressing gastrointestinal disorders affecting the enteric nervous system. Their core products target critical health issues such as nausea and vomiting associated with GLP-1 agonists and gastroparesis, improving patient outcomes by effectively managing symptoms that significantly impact quality of life.Neurogastrx generates revenue through the commercialization of its specialized products targeting gastrointestinal disorders. The company operates primarily through partnerships with healthcare institutions that prescribe its therapies. aims to advance its pipeline of gastrointestinal therapies for serious conditions. The strategic focus includes enhancing product access and integrating new therapies into healthcare systems.
Who invested in Neurogastrx
7 investors across 2 rounds
See all investors in Neurogastrx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurogastrx
Who invested in Neurogastrx?
Neurogastrx has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurogastrx raised?
Neurogastrx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurogastrx last raise money?
Neurogastrx's most recent round on record is a Series B, in Aug 2021.
What does Neurogastrx do?
Neurogastrx is a pharmaceuticals company.
Where is Neurogastrx headquartered?
Neurogastrx is headquartered in Woburn, US.
Which VCs invest in companies like Neurogastrx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Neurogastrx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Neurogastrx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.